JPRN-UMIN000021492已完成未知
To investigate the safety of switch from infliximab biosimilar 1 in rheumatoid arthritis patients. - Switch from infliximab to infliximab biosimilar 1 in rheumatoid arthritis patients.
Inoue Hospital0 个研究点目标入组 40 人开始时间: 2016年3月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients who corresponds to a contraindication of infliximab of infliximab biosimilar 1 2.Patients their doctors find not appropriate for this study
研究者
相似试验
已完成
不适用
Evaluation of the Switch From the Original Infliximab to Its Biosimilar in Daily Practice at Cochin HospitalSpondyloarthritisRheumatoid ArthritisCrohn's DiseaseUveitisNCT02998398Assistance Publique - Hôpitaux de Paris262
已完成
不适用
Pilot study of index and safety of switching to Denosumab from Zoledronic acid for hepatocellular carcinoma with bone metastasis.JPRN-UMIN000009675Department of Gastroenterology and Metabolism,Hiroshima University Hospital35
已完成
不适用
Evaluation of the efficacy and safety for switching from premixed insulin to ultra-long acting insulin plus ultra-rapid insulitype 2 diabetesJPRN-UMIN000009562Department of Endocrinology and Metabolism, Nagoya City West Medical Center40
已完成
不适用
Investigation of efficacy and safety of switching from basal-bolus therapy to combination therapy with GLP-1 receptor agonist and basal insulin injection in type 2 diabetestype 2 diabetesJPRN-UMIN000013222Juntendo University Graduate School of Medicine30
尚未招募
Unknown
Study of the effectiveness and safety of switching from JAK inhibitors to non-TNF biologics in elderly patients with rheumatoid arthritisRheumatoid arthritisJPRN-UMIN000050387Kawasaki Medical School30